FDA approved its drug-coated device to treat coronary in-stent restenosis (ISR) in patients with a type of heart disease . The device is branded Agent and will launch in the coming months .ISR involves accumulation of plaque or scar tissue under the stent .
#HEALTH #English #IN
Read more at ETHealthWorld